Human RGM249-derived small RNAs potentially regulate tumor malignancy

Nucleic Acid Therapeutics

Volumn 23, Issue 5, 2013, Pages 332-343

  Miura, Norimasa ^a   Shimizu, Mika ^a   Shinoda, Waka ^a   Tsuno, Satoshi ^a   Sato, Reina ^a   Wang, Xinhui ^a   Jo, Jun Ichiro ^b   Tabata, Yasuhiko ^b   Hasegawa, Junichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICROSPHERE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; UNTRANSLATED RNA 249;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DIFFERENTIATION; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDROGEL; IN VIVO STUDY; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; GENETIC THERAPY; HUMANS; IMMUNOCOMPROMISED HOST; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MELANOMA; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NUCLEIC ACID CONFORMATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN NEOPLASMS;

EID: 84883370981     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2013.0424     Document Type: Article

References (52)

1. ALTUVIA, Y., LANDGRAF, P., LITHWICK, G., ELEFANT, N., PFEFFER, S., ARAVIN, A., BROWNSTEIN, M.J., TUSCHL, T., and MARGALIT, H. (2005). Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33, 2697-2706.
2. ALVAREZ, R., ELBASHIR, S., BORLAND, T., TOUDJARSKA, I., HADWIGER, P., JOHN, M., ROEHL, I., MORSKAYA, S.S., MARTINELLO, R., KAHN, J., et al. (2009). RNA interferencemediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob. Agents Chemother. 253, 3952-3962.
3. BEHLKE, M.A. (2006). Progress towards in vivo use of siRNAs. Mol. Ther. 13, 644-670.
4. BERNSTEIN, E., KIM, S.Y., CARMELL, M.A., MURCHISON, E.P., ALCORN, H., LI, M.Z., MILLS, A.A., ELLEDGE, S.J., ANDERSON, K.V., and HANNON, G.J. (2003). Dicer is essential for mouse development. Nat. Genet. 35, 215-217.
5. BHUTANI, N., BRADY, J.J., DAMIAN, M., SACCO, A., CORBEL, S.Y., and BLAU, H.M. (2010). Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463, 1042-1047.
6. CARETTE, J.E., PRUSZAK, J., VARADARAJAN, M., BLOMEN, V.A., GOKHALE, S., CAMARGO, F.D., WERNIG, M., JAENISCH, R., BRUMMELKAMP, T.R. (2010). Generation of iPSCs from cultured human malignant cells. Blood 115, 4039-4042.
7. CASTANOTTO, D., and ROSSI, J.J. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426-433.
8. CHAN, J.A., KRICHEVSKY, A.M., and KOSIK, K.S. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029-6033.
9. CHEN, C.Z., LI, L., LODISH, H.F., and BARTEL, D.P. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86.
10. CIMMINO, A., CALIN, G.A., FABBRI, M., IORIO, M.V., FERRACIN, M., SHIMIZU, M., WOJCIK, S.E., AQEILAN, R.I., ZUPO, S., DONO, M., et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 102, 13944-13949.
11. DAVIS, M.E., ZUCKERMAN, J.E., CHOI, C.H., SELIGSON, D., TOLCHER, A., ALABI, C.A., YEN, Y., HEIDEL, J.D., and RIBAS, A. (2010). Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067-1070.
12. DEVINCENZO, J., CEHELSKY, J.E., ALVAREZ, R., ELBASHIR, S., HARBORTH, J., TOUDJARSKA, I., NECHEV, L., MURUGAIAH, V., VAN VLIET, A., VAISHNAW, A.K., et al. (2008). Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Res 77, 225-231.
13. DOENCH, J.G., PETERSEN, C.P., and SHARP, P.A. (2003). siRNAs can function as miRNAs. Genes Dev. 17, 438-442.
14. DOENCH, J.G., and SHARP, P.A. (2004). Specificity of micro-RNA target selection in translational repression. Genes Dev. 18, 504-511.
15. GHILDIYAL, M. and ZAMORE, P.D. (2009). Small silencing RNAs: An expanding universe. Nat. Rev. Genet. 10, 94-108.
16. GOODARZI, H., ELEMENTO, O., and TAVAZOIE, S. (2009). Revealing global regulatory perturbations across human cancers. Mol. Cell. 36, 900-911.
17. GUNARATNE, P.H. (2009). Embryonic stem cell microRNAs: Defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?. Curr. Stem Cell Res. Ther. 4, 168-177.
18. ILIOPOULOS, D., HIRSCH, H.A., and STRUHL, K. (2009). An epigenetic switch involving NF-kappaB, Lin28, Let-7 Micro-RNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706.
19. JEANG, K.T. (2010). Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?. Oncotarget 1, 453-456.
20. JO, J., YAMAMOTO, M., MATSUMOTO, K., NAKAMURA, T., and TABATA, Y. (2006). Liver targeting of plasmid DNA with a cationized pullulan for tumor suppression. J. Nanosci. Nanotechnol. 6, 2853-2859.
21. KANELLOPOULOU, C., MULJO, S.A., KUNG, A.L., GANESAN, S., DRAPKIN, R., JENUWEIN, T., LIVINGSTON, D.M., and RAJEWSKY, K. (2005). Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 19, 489-501.
22. KIMURA, Y., and TABATA, Y. (2010). Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J. Biomater. Sci. Polym. Ed. 21, 37-51.
23. KOH W., SHENG, C.T., TAN, B., LEE, Q.Y., KUZNETSOV, V., KIANG, L.S., and TANAVDE, V. (2010). Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. BMC Genomics 11 (Suppl 1), S6.
24. KUSHIBIKI, T., NAGATA-NAKAJIMA, N., SUGAI, M., SHIMIZU, A., and TABATA, Y. (2006). Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type 2 receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds. J. Control. Release 110, 610-617.
25. LAGOS-QUINTANA, M., RAUHUT, R., LENDECKEL, W., and TUSCHL, T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858.
26. LANDGRAF, P., RUSU, M., SHERIDAN, R., SEWER, A., IOVINO, N., ARAVIN, A., PFEFFER, S., RICE, A., KAMPHORST, A.O., LANDTHALER, M., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
27. LAU, N.C., LIM, L.P., WEINSTEIN, E.G., and BARTEL, D.P. (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858-862.
28. LEACHMAN, S.A., HICKERSON, R.P., SCHWARTZ, M.E., BULLOUGH, E.E., HUTCHERSON, S.L., BOUCHER, K.M., HANSEN, C.D., ELIASON, M.J., SRIVATSA, G.S., KORNBRUST, D.J., et al. (2010). First-in-human mutation-targeted siRNA phase 1b trial of an inherited skin disorder. Mol. Ther. 18, 442-446.
29. LIAO, R., SUN, J., ZHANG, L., LOU, G., CHEN, M., ZHOU, D., CHEN, Z., and ZHANG, S. (2008). MicroRNAs play a role in the development of human hematopoietic stem cells. J. Cell Biochem. 104, 805-817.
30. LIU, J., VALENCIA-SANCHEZ, M.A., HANNON, G.J., and PARKER, R. (2005). MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7, 719-723.
31. MA, L., TERUYA-FELDSTEIN, J., and WEINBERG, R.A. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688.
32. MELTZER, P.S. (2005). Cancer genomics: Small RNAs with big impacts. Nature 435, 745-746.
33. MENG, F., HENSON, R., WEHBE-JANEK, H., GHOSHAL, K., JACOB, S.T., and PATEL, T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658.
34. MIURA, N., NAKAMURA, H., SATO, R., TSUKAMOTO, T., HADARA, T., TAKAHASHI, S., ADACHI, Y., SHOMORI, K., SANO, A., KISHIMOTO, Y., et al. (2006). Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci. 97, 1366-1373.
35. MIURA, N., SATO, R., TSUKAMOTO, T., SHIMIZU, M., KABASHIMA, H., TAKEDA, M., TAKAHASHI, S., HARADA, T., WEST, J.E., DRABKIN, H., et al. (2009). A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT. BMC Mol. Biol. 10, 5.
36. MIYOSHI, N., ISHII, H., NAGAI, K., HOSHINO, H., MIMORI, K., TANAKA, F., NAGANO, H., SEKIMOTO, M., DOKI, Y., and MORI, M. (2010). Defined factors induce reprogramming of gastrointestinal cancer cells. Proc. Natl. Acad. Sci. U. S. A. 107, 40-45.
37. MU, P., NAGAHARA, S., MAKITA, N., TARUMI, Y., KADOMATSU, K., and TAKEI, Y. (2009). Systemic delivery of siRNA specific to tumor mediated by atelocollagen: Combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer. Int. J. Cancer 125, 2978-2990.
38. NAGATA, S., TOYODA, M., YAMAGUCHI, S., HIRANO, K., MAKINO, H., NISHINO, K., MIYAGAWA, Y., OKITA, H., KIYOKAWA, N., NAKAGAWA, M., et al. (2009). Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells 14, 1395-1404.
39. NAKASHIMA, K., COLAMARINO, S., and GAGE, F.H. (2004). Embryonic stem cells: Staying plastic on plastic. Nat. Med. 10, 23-24.
40. OKITA, K., HONG, H., TAKAHASHI, K., and YAMANAKA, S. (2010). Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat. Protoc. 5, 418-428.
41. PATRU,C., ROMAO, L.,VARLET, P.,COULOMBEL, L., RAPONI, E., CADUSSEAU, J., RENAULT-MIHARA, F., THIRANT, C., LEONARD,N.,BERHNEIM, A., et al. (2010).CD133,CD15/SSEA- 1, CD34, or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer 10, 66.
42. PEKARSKY, Y., and CROCE, C.M. (2010). Is miR-29 an oncogene or tumor suppressor in CLL?. Oncotarget 1, 224-227.
43. PERSENGIEV, S.P., ZHU, X., and GREEN, M.R. (2004). Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18.
44. REN, J., JIN, P., WANG, E., MARINCOLA, F.M., and STRONCEK, D.F. (2009). MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J. Transl. Med. 7, 20.
45. SATZGER, I., MATTERN, A., KUETTLER, U., WEINSPACH, D., VOELKER, B., KAPP, A., and GUTZMER, R. (2010). MicroRNA- 15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int. J. Cancer. 126, 2553-2562.
46. SUH, M.R., LEE, Y., KIM, J.Y., KIM, S.K., MOON, S.H., LEE, J.Y., CHA, K.Y., CHUNG, H.M., YOON, H.S., MOON, S.Y., et al. (2004). Human embryonic stem cells express a unique set of microRNAs. Dev. Biol. 270, 488-498.
47. TABU, K., KIMURA, T., SASAI, K., WANG, L., BIZEN, N., NISHIHARA, H., TAGA, T., and TANAKA, S. (2010). Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Mol. Cancer 9, 39.
48. TAKAMIZAWA, J., KONISHI, H., YANAGISAWA, K., TOMIDA, S., OSADA, H., ENDOH, H., HARANO, T., YATABE, Y., NAGINO, M., NIMURA, Y., et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756.
49. TAKESHITA, F., PATRAWALA, L., OSAKI, M., TAKAHASHI, R.U., YAMAMOTO, Y., KOSAKA, N., KAWAMATA, M., KELNAR, K., BADER, A.G., BROWN, D., et al. (2010). Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther. 18, 181-187.
50. THUM, T., GALUPPO, P., WOLF, C., FIEDLER, J., KNEITZ, S., VAN LAAKE, L.W., DOEVENDANS, P.A., MUMMERY, C.L., BORLAK, J., HAVERICH, A., et al. (2007). MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 116, 258-267.
51. UTIKAL, J., MAHERALI, N., KULALERT, W., and HOCHEDLINGER, K. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502-3510.
52. VISWANATHAN, S.R., DALEY, G.Q., and GREGORY, R.I (2008). Selective blockade of microRNA processing by Lin28. Science 320, 97-100.